Skip to main content
SpringerLink
Log in

Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias

  • Review
  • Published:
European Journal of Clinical Microbiology & Infectious Diseases Aims and scope Submit manuscript

Abstract

Bloodstream infections (BSIs) remain as life-threatening complications and are associated with significant morbidity and mortality among solid organ transplant (SOT) recipients. Multidrug-resistant (MDR) Gram-negative bacteria can cause serious bacteremias in these recipients. Reviews have aimed to investigate MDR Gram-negative bacteremias; however, they were lacking in SOT recipients in the past. To better understand the characteristics of bacteremias due to MDR Gram-negative bacteria, optimize preventive and therapeutic strategies, and improve the outcomes of SOT recipients, this review summarize the epidemiology, clinical and laboratory characteristics, and explores the mechanisms, prevention, and treatment of MDR Gram-negative bacteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fishman JA (2007) Infection in solid-organ transplant recipients. N Engl J Med 357:2601–2614

    Article  CAS  PubMed  Google Scholar 

  2. Moreno A, Cervera C, Gavaldá J et al (2007) Bloodstream infections among transplant recipients: results of a nationwide surveillance in Spain. Am J Transplant 7:2579–2586

    Article  CAS  PubMed  Google Scholar 

  3. Kusne S, Dummer JS, Singh N et al (1988) Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) 67:132–143

    Article  CAS  Google Scholar 

  4. George DL, Arnow PM, Fox AS et al (1991) Bacterial infection as a complication of liver transplantation: epidemiology and risk factors. Rev Infect Dis 13:387–396

    Article  CAS  PubMed  Google Scholar 

  5. Wagener MM, Yu VL (1992) Bacteremia in transplant recipients: a prospective study of demographics, etiologic agents, risk factors, and outcomes. Am J Infect Control 20:239–247

    Article  CAS  PubMed  Google Scholar 

  6. Singh N, Gayowski T, Wagener MM et al (1997) Bloodstream infections in liver transplant recipients receiving tacrolimus. Clin Transplant 11:275–281

    CAS  PubMed  Google Scholar 

  7. Candel FJ, Grima E, Matesanz M et al (2005) Bacteremia and septic shock after solid-organ transplantation. Transplant Proc 37:4097–4099

    Article  CAS  PubMed  Google Scholar 

  8. Singh N, Wagener MM, Obman A et al (2004) Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver Transpl 10:844–849

    Article  PubMed  Google Scholar 

  9. Singh N, Gayowski T, Rihs JD et al (2001) Evolving trends in multiple-antibiotic-resistant bacteria in liver transplant recipients: a longitudinal study of antimicrobial susceptibility patterns. Liver Transplant 7:22–26

    Article  CAS  Google Scholar 

  10. Sigurdsson L, Reyes J, Kocoshis SA et al (2000) Bacteremia after intestinal transplantation in children correlates temporally with rejection or gastrointestinal lymphoproliferative disease. Transplantation 70:302–305

    Article  CAS  PubMed  Google Scholar 

  11. Shields RK, Minces L, Kwak EJ et al (2010) Bloodstream infections in intestinal transplant recipients are associated with low mortality rates despite the predominance of late-onset infections and the emergence of Serratia and other gram-negative bacteria. In: Proceedings of the 48th Annual Meeting of the Infectious Diseases Society of America (IDSA), Vancouver, BC, Canada, October 21–24, 2010. Abstract 1255

  12. Kim SI, Kim YJ, Jun YH et al (2009) Epidemiology and risk factors for bacteremia in 144 consecutive living-donor liver transplant recipients. Yonsei Med J 50:112–121

    Article  PubMed Central  PubMed  Google Scholar 

  13. Iida T, Kaido T, Yagi S et al (2010) Posttransplant bacteremia in adult living donor liver transplant recipients. Liver Transpl 16:1379–1385

    Article  PubMed  Google Scholar 

  14. Hsu J, Andes DR, Knasinski V et al (2009) Statins are associated with improved outcomes of bloodstream infection in solid-organ transplant recipients. Eur J Clin Microbiol Infect Dis 28:1343–1351

    Article  CAS  PubMed  Google Scholar 

  15. Singh RP, Farney AC, Rogers J et al (2008) Analysis of bacteremia after pancreatic transplantation with enteric drainage. Transplant Proc 40:506–509

    Article  CAS  PubMed  Google Scholar 

  16. Rabkin DG, Stifelman MD, Birkhoff J et al (1998) Early catheter removal decreases incidence of urinary tract infections in renal transplant recipients. Transplant Proc 30:4314–4316

    Article  CAS  PubMed  Google Scholar 

  17. Osman Y, Ali-El-Dein B, Shokeir AA et al (2005) Routine insertion of ureteral stent in live-donor renal transplantation: is it worthwhile? Urology 65:867–871

    Article  PubMed  Google Scholar 

  18. Wade JJ, Rolando N, Hayllar K et al (1995) Bacterial and fungal infections after liver transplantation: an analysis of 284 patients. Hepatology 21:1328–1336

    Article  CAS  PubMed  Google Scholar 

  19. Kim HK, Park YK, Wang HJ et al (2013) Epidemiology and clinical features of post-transplant bloodstream infection: an analysis of 222 consecutive liver transplant recipients. Infect Chemother 45:315–324

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Bratu S, Mooty M, Nichani S et al (2005) Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob Agents Chemother 49:3018–3020

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Bratu S, Tolaney P, Karumudi U et al (2005) Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 56:128–132

    Article  CAS  PubMed  Google Scholar 

  22. Shields RK, Clancy CJ, Gillis LM et al (2012) Epidemiology, clinical characteristics and outcomes of extensively drug-resistant Acinetobacter baumannii infections among solid organ transplant recipients. PLoS One 7:e52349

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Shields RK, Kwak EJ, Potoski BA et al (2011) High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen. Diagn Microbiol Infect Dis 70:246–252

    Article  CAS  PubMed  Google Scholar 

  24. van Duin D, van Delden C; AST Infectious Diseases Community of Practice (2013) Multidrug-resistant gram-negative bacteria infections in solid organ transplantation. Am J Transplant 13(Suppl 4):31–41

    Article  PubMed  Google Scholar 

  25. Magiorakos AP, Srinivasan A, Carey RB et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18:268–281

    Article  CAS  PubMed  Google Scholar 

  26. Serefhanoglu K, Timurkaynak F, Arslan H et al (2011) Bacteremia among liver and kidney transplant recipients: etiologic agents and antimicrobial susceptibilities. Braz J Infect Dis 15:408–409

    Article  PubMed  Google Scholar 

  27. Linares L, García-Goez JF, Cervera C et al (2009) Early bacteremia after solid organ transplantation. Transplant Proc 41:2262–2264

    Article  CAS  PubMed  Google Scholar 

  28. Cervera C, van Delden C, Gavaldà J et al (2014) Multidrug-resistant bacteria in solid organ transplant recipients. Clin Microbiol Infect 20(Suppl 7):49–73

    Article  PubMed  Google Scholar 

  29. Clancy CJ, Chen L, Shields RK et al (2013) Epidemiology and molecular characterization of bacteremia due to carbapenem-resistant Klebsiella pneumoniae in transplant recipients. Am J Transplant 13:2619–2633

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  30. Kalpoe JS, Sonnenberg E, Factor SH et al (2012) Mortality associated with carbapenem-resistant Klebsiella pneumoniae infections in liver transplant recipients. Liver Transpl 18:468–474

    Article  PubMed  Google Scholar 

  31. Sganga G, Spanu T, Bianco G et al (2012) Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles. Transplant Proc 44:1973–1976

    Article  CAS  PubMed  Google Scholar 

  32. Johnson LE, D’Agata EM, Paterson DL et al (2009) Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients. Transpl Infect Dis 11:227–234

    Article  CAS  PubMed  Google Scholar 

  33. Bodro M, Sabé N, Tubau F et al (2013) Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients. Transplantation 96:843–849

    Article  PubMed  Google Scholar 

  34. Silveira FP, Marcos A, Kwak EJ et al (2006) Bloodstream infections in organ transplant recipients receiving alemtuzumab: no evidence of occurrence of organisms typically associated with profound T cell depletion. J Infect 53:241–247

    Article  PubMed  Google Scholar 

  35. Bodro M, Sabé N, Tubau F et al (2014) Extensively drug-resistant Pseudomonas aeruginosa bacteremia in solid organ transplant recipients. Transplantation

  36. Linares L, Cervera C, Cofán F et al (2007) Epidemiology and outcomes of multiple antibiotic-resistant bacterial infection in renal transplantation. Transplant Proc 39:2222–2224

    Article  CAS  PubMed  Google Scholar 

  37. Doumith M, Ellington MJ, Livermore DM et al (2009) Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J Antimicrob Chemother 63:659–667

    Article  CAS  PubMed  Google Scholar 

  38. Gupta N, Limbago BM, Patel JB et al (2011) Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 53:60–67

    Article  PubMed  Google Scholar 

  39. Nordmann P, Cuzon G, Naas T (2009) The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 9:228–236

    Article  CAS  PubMed  Google Scholar 

  40. Arnold RS, Thom KA, Sharma S et al (2011) Emergence of Klebsiella pneumoniae carbapenemase-producing bacteria. South Med J 104:40–45

    Article  PubMed Central  PubMed  Google Scholar 

  41. Mathers AJ, Hazen KC, Carroll J et al (2013) First clinical cases of OXA-48-producing carbapenem-resistant Klebsiella pneumoniae in the United States: the “menace” arrives in the new world. J Clin Microbiol 51:680–683

    Article  PubMed Central  PubMed  Google Scholar 

  42. Patel G, Bonomo RA (2013) “Stormy waters ahead”: global emergence of carbapenemases. Front Microbiol 4:48

    Article  PubMed Central  PubMed  Google Scholar 

  43. Poole K (2001) Multidrug efflux pumps and antimicrobial resistance in Pseudomonas aeruginosa and related organisms. J Mol Microbiol Biotechnol 3:255–264

    CAS  PubMed  Google Scholar 

  44. Shahcheraghi F, Nikbin VS, Feizabadi MM (2010) Identification and genetic characterization of metallo-beta-lactamase-producing strains of Pseudomonas aeruginosa in Tehran, Iran. New Microbiol 33:243–248

    CAS  PubMed  Google Scholar 

  45. Jalal S, Wretlind B (1998) Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa. Microb Drug Resist 4:257–261

    Article  CAS  PubMed  Google Scholar 

  46. Li XZ, Zhang L, Poole K (2000) Interplay between the MexA-MexB-OprM multidrug efflux system and the outer membrane barrier in the multiple antibiotic resistance of Pseudomonas aeruginosa. J Antimicrob Chemother 45:433–436

    Article  CAS  PubMed  Google Scholar 

  47. Snitkin ES, Zelazny AM, Thomas PJ et al (2012) Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 4:148ra116

    Article  PubMed Central  PubMed  Google Scholar 

  48. Jacob JT, Klein E, Laxminarayan R et al (2013) Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 62:165–170

    Google Scholar 

  49. Bishara J, Goldberg E, Lev S et al (2012) The utilization of solid organs for transplantation in the setting of infection with multidrug-resistant organisms: an expert opinion. Clin Transplant 26:811–815

    Article  PubMed  Google Scholar 

  50. Campfield B, Chen K, Kolls JK (2014) Vaccine approaches for multidrug resistant Gram negative infections. Curr Opin Immunol 28:84–89

    Article  CAS  PubMed  Google Scholar 

  51. Nguyen M, Eschenauer GA, Bryan M et al (2010) Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Diagn Microbiol Infect Dis 67:180–184

    Article  PubMed  Google Scholar 

  52. Patel G, Huprikar S, Factor SH et al (2008) Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29:1099–1106

    Article  PubMed  Google Scholar 

  53. Levin AS, Barone AA, Penço J et al (1999) Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. Clin Infect Dis 28:1008–1011

    Article  CAS  PubMed  Google Scholar 

  54. Jones RN, Biedenbach DJ, Gales AC (2003) Sustained activity and spectrum of selected extended-spectrum beta-lactams (carbapenems and cefepime) against Enterobacter spp. and ESBL-producing Klebsiella spp.: report from the SENTRY antimicrobial surveillance program (USA, 1997–2000). Int J Antimicrob Agents 21:1–7

    Article  CAS  PubMed  Google Scholar 

  55. Sun HY, Shields RK, Cacciarelli TV et al (2010) A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient. Transpl Infect Dis 12:555–560

    Article  PubMed  Google Scholar 

  56. Meachery G, De Soyza A, Nicholson A et al (2008) Outcomes of lung transplantation for cystic fibrosis in a large UK cohort. Thorax 63:725–731

    Article  CAS  PubMed  Google Scholar 

  57. Falagas ME, Valkimadi P-E, Huang Y-T et al (2008) Therapeutic options for Stenotrophomonas maltophilia infections beyond co-trimoxazole: a systematic review. J Antimicrob Chemother 62:889–894

    Article  CAS  PubMed  Google Scholar 

  58. Boussaud V, Guillemain R, Grenet D et al (2008) Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Thorax 63:732–737

    Article  CAS  PubMed  Google Scholar 

  59. Alexander BD, Petzold EW, Reller LB et al (2008) Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex. Am J Transplant 8:1025–1030

    Article  CAS  PubMed  Google Scholar 

  60. Patel G, Rana MM, Huprikar S (2013) Multidrug-resistant bacteria in organ transplantation: an emerging threat with limited therapeutic options. Curr Infect Dis Rep 15:504–513

    Article  PubMed  Google Scholar 

  61. Hirsch EB, Ledesma KR, Chang KT et al (2012) In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria. Antimicrob Agents Chemother 56:3753–3757

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  62. Livermore DM, Mushtaq S, Warner M et al (2011) Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae. Antimicrob Agents Chemother 55:390–394

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  63. Mushtaq S, Warner M, Williams G et al (2010) Activity of chequerboard combinations of ceftaroline and NXL104 versus beta-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother 65:1428–1432

    Article  CAS  PubMed  Google Scholar 

  64. Aktaş Z, Kayacan C, Oncul O (2012) In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae. Int J Antimicrob Agents 39:86–89

    Article  PubMed  Google Scholar 

  65. Aggen JB, Armstrong ES, Goldblum AA et al (2010) Synthesis and spectrum of the neoglycoside ACHN-490. Antimicrob Agents Chemother 54:4636–4642

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  66. Endimiani A, Hujer KM, Hujer AM et al (2009) ACHN-490, a neoglycoside with potent in vitro activity against multidrug-resistant Klebsiella pneumoniae isolates. Antimicrob Agents Chemother 53:4504–4507

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  67. Landman D, Kelly P, Bäcker M et al (2011) Antimicrobial activity of a novel aminoglycoside, ACHN-490, against Acinetobacter baumannii and Pseudomonas aeruginosa from New York City. J Antimicrob Chemother 66:332–334

    Article  CAS  PubMed  Google Scholar 

  68. Livermore DM, Mushtaq S, Warner M et al (2011) Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates. J Antimicrob Chemother 66:48–53

    Article  CAS  PubMed  Google Scholar 

  69. Sutcliffe JA (2011) Antibiotics in development targeting protein synthesis. Ann N Y Acad Sci 1241:122–152

    Article  CAS  PubMed  Google Scholar 

  70. Juan C, Zamorano L, Pérez JL et al (2010) Activity of a new antipseudomonal cephalosporin, CXA-101 (FR264205), against carbapenem-resistant and multidrug-resistant Pseudomonas aeruginosa clinical strains. Antimicrob Agents Chemother 54:846–851

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. Sader HS, Rhomberg PR, Farrell DJ et al (2011) Antimicrobial activity of CXA-101, a novel cephalosporin tested in combination with tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis strains having various resistance phenotypes. Antimicrob Agents Chemother 55:2390–2394

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  72. Pop-Vicas A, Opal SM (2014) The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock. Virulence 5:206–212

    Article  PubMed Central  PubMed  Google Scholar 

  73. Diazgranados CA, Cardo DM, McGowan JE Jr (2008) Antimicrobial resistance: international control strategies, with a focus on limited-resource settings. Int J Antimicrob Agents 32:1–9

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

No conflicts of interest for all authors.

Author information

Authors and Affiliations

  1. Department of Transplant Surgery, the Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China

    QQ. Wan & QF. Ye

  2. Center for Experimental Medical Research, the Third Xiangya Hospital, Central South University, No. 138 Tongzipo Road, Changsha, 410013, Hunan, China

    H. Yuan

Authors
  1. QQ. Wan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. QF. Ye
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. Yuan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wan, Q., Ye, Q. & Yuan, H. Multidrug-resistant Gram-negative bacteria in solid organ transplant recipients with bacteremias. Eur J Clin Microbiol Infect Dis 34, 431–437 (2015). https://doi.org/10.1007/s10096-014-2271-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10096-014-2271-z

Keywords

Search

Navigation